AS04-adjuvanted human papillomavirus types 16/18 vaccine (Cervarix®): a guide to its use

Author： Lyseng-Williamson Katherine A.   McKeage Kate  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.3, 2012-03, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™]

By Keam Susan J.  

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite

Human papillomavirus types 16 and 18 vaccine (Cervarix™): a guide to its use in the prevention of cervical cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 6, 2008-06 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

A bivalent human papillomavirus (HPV)-16/18 L1 virus-like particle AS04 vaccine may not increase viral clearance

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cervarix vaccine [human papillomavirus vaccine MEDI-517] has been granted WHO prequalification in developing nations

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite